IQVIA
IQVIA18About
What does IQVIA do?
IQVIA is a global provider of advanced analytics, technology solutions, and contract research services to the life sciences industry. They aim to help pharmaceutical, biotech, and medical device companies bring treatments to patients more effectively and efficiently. Their offerings span clinical development, commercialization, and real-world evidence generation.
What is IQVIA's revenue?
StartupHub estimates IQVIA's annual revenue at $24.4B (range $15.0B to $37.9B, 67% confidence), based on comparable companies in the sector.
What is IQVIA's valuation?
StartupHub estimates IQVIA's effective valuation at $72.0B (range $32.5B to $129.4B, 57% confidence), based on comparable companies in the sector.
Where is IQVIA headquartered?
IQVIA is headquartered in Durham, United States.
When was IQVIA founded?
IQVIA was founded in 2016.
What industry does IQVIA operate in?
IQVIA operates in Healthcare, Life Sciences, Data Analytics, Technology, AI, Clinical Research.
How many employees does IQVIA have?
IQVIA has approximately 80000 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Biotalent is a platform that streamlines biotech hiring by connecting qualified candidates with job opportunities and providing hiring teams with tools for efficient candidate review.
AI-powered platform accelerating biological research and drug discovery.
A healthcare and life sciences consulting firm leveraging AI and data analytics for strategic solutions.
Empowering Life Science Entrepreneurs for Innovative Healthcare Solutions.
An entrant is a company tagged Life Sciences whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.